ERIK WISNIEWSKI: Open Payments
NPI 1992201925 · GARDNER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 16 payments from 9 companies in 2025. Trend: 2023 $510 · 2024 $481 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $91 |
| ABBVIE INC. | 3 | $70 |
| Exact Sciences Corporation | 2 | $43 |
| Astellas Pharma US Inc | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Pulmonx Corporation | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: ELIQUIS, VRAYLAR, The Cologuard Plus Collection Kit, Veozah, TRELEGY ELLIPTA, PREVNAR 20, CHARTIS CATHETER, QULIPTA.
Industry payments across MA — which companies pay providers there.
